Cargando…

Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing

Detalles Bibliográficos
Autor principal:	Seiler, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837304/ https://www.ncbi.nlm.nih.gov/pubmed/27141457 http://dx.doi.org/10.21037/tau.2016.02.01

Ejemplares similares

Fasciotomy for chronic exertional compartment syndrome remains controversial
por: Samson, Russell H.
Publicado: (2020)

Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture
por: Mi, Haoyang, et al.
Publicado: (2021)

Comment on “Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer”
por: Altundag, Kadri
Publicado: (2017)

Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020)

Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
por: Miyagi, Hiroko, et al.
Publicado: (2022)

Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
por: Loong, Herbert H., et al.
Publicado: (2018)

Editorial comment: the effect of neoadjuvant chemotherapy on tumour downstaging and outcomes in patients with muscle invasive bladder cancers
por: Ismaili, Nabil
Publicado: (2020)

Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy
por: Font, Albert, et al.
Publicado: (2020)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Role of Axillary Surgery After Neoadjuvant Chemotherapy
por: Cavalcante, Francisco Pimentel, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy in Invasive Bladder Cancer
por: Oliver, R.T.D.
Publicado: (1991)

Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
por: Sherif, Amir, et al.
Publicado: (2018)

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
por: Ács, Balázs, et al.
Publicado: (2017)

Breast screening remains a controversial issue
por: Harris, A L
Publicado: (2013)

Gene patents remain controversial in biomedical research
por: Arnold, Carrie
Publicado: (2013)

The Genome Russia project: closing the largest remaining omission on the world Genome map
por: Oleksyk, Taras K., et al.
Publicado: (2015)

Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
por: Wezel, Felix, et al.
Publicado: (2017)

Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer
por: Kim, YongHwan, et al.
Publicado: (2023)

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
por: Xylinas, Evanguelos, et al.
Publicado: (2016)

Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
por: Goel, Arun Kumar, et al.
Publicado: (2010)

Progress and controversies in developing cancer vaccines
por: Slingluff, Craig L, et al.
Publicado: (2005)

Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
por: Christensen, Emil, et al.
Publicado: (2023)

Prediction of neoadjuvant chemotherapy response in breast cancer
por: Myllys, Maiju
Publicado: (2021)

Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study
por: Jhuo, Yu-Cing, et al.
Publicado: (2023)

Controversy: Botulinum Toxin in Pregnancy
por: Paul, Munish
Publicado: (2009)

Adherens junctions remain dynamic
por: Falk, Matthias M
Publicado: (2010)

Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer
por: Kneubil, M.C., et al.
Publicado: (2022)

Airway Surface Liquid: End of the Controversy?
por: Landry, Jennifer S., et al.
Publicado: (2001)

Proliferation/quiescence: the controversial "aller-retour"
por: Daignan-Fornier, Bertrand, et al.
Publicado: (2011)

Depression in primary care: challenges & controversies
por: Avasthi, Ajit, et al.
Publicado: (2014)

Controversy Over Bullets and in the Bully Pulpit
Publicado: (2001)

The Hemodialysis Access Surveillance Controversy Continues
por: Anvari, Evamaria, et al.
Publicado: (2020)

Challenges and Controversies to Testing for COVID-19
por: Binnicker, Matthew J.
Publicado: (2020)

Commentary: Controversies related to endogenous endophthalmitis
por: Babu, Naresh, et al.
Publicado: (2020)

Endometriosis – novel approaches and controversies debated
por: Foster, W G, et al.
Publicado: (2021)

Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer
por: Tervahartiala, Minna, et al.
Publicado: (2017)

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
por: Hinsenveld, F. J., et al.
Publicado: (2021)

Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19
por: Carlet, Jean, et al.
Publicado: (2020)

To Correct or Not Correct? Actual Evidence, Controversy and the Questions That Remain Open
por: García García, Miguel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f9m5nivuv5voafvd0kts95115q